Revisions of 'Glioblastoma NOS'
-
Revision 7 - major - created about 2 years ago by Dalia Ibrahim ◉ - view changesetDate: 2023-02-23 20:32:43 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Mohammad Taghi Niknejad -
Revision 6 - major - created about 2 years ago by Dalia Ibrahim ◉ - view changesetDate: 2023-02-23 16:18:11 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Frank Gaillard -
Revision 5 - major - created about 2 years ago by Joshua Yap ◉ ◈ - view changesetDate: 2023-02-16 09:16:42 UTC Disclosures:
At the time the revision was created Joshua Yap had no financial relationships to ineligible companies to disclose.
View Joshua Yap's current disclosures Reviewed by: Ammar Haouimi -
Revision 4 - major - created about 2 years ago by Frank Gaillard ◉ ◈ - view changesetDate: 2023-02-16 04:19:50 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Joshua Yap -
Revision 3 - major - created about 2 years ago by Jeremy Jones ◉ - view changesetDate: 2023-02-14 11:02:23 UTC Disclosures:
At the time the revision was created Jeremy Jones had no financial relationships to ineligible companies to disclose.
View Jeremy Jones's current disclosures Reviewed by: Joachim Feger -
Revision 2 - major - created about 2 years ago by Dalia Ibrahim ◉ - view changesetDate: 2023-02-12 12:43:56 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Jeremy Jones -
Revision 1 - major - created about 2 years ago by Dalia Ibrahim ◉ - view changesetDate: 2023-02-12 10:23:40 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Jeremy Jones
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.